Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $710.7250 (2.11%) ($710.7250 - $711.1900) on Wed. Jan. 11, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.73% (three month average) | RSI | 42 | Latest Price | $710.7250(2.11%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.4% a day on average for past five trading days. | Weekly Trend | REGN declines -1.2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(49%) XLV(45%) DIA(32%) VYM(32%) SPLV(29%) | Factors Impacting REGN price | REGN will decline at least -0.865% in a week (0% probabilities). VIXM(-13%) VXX(-8%) EDOC(-8%) IGOV(-3%) TBT(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.865% (StdDev 1.73%) | Hourly BBV | 1.4 () | Intraday Trend | 0% | | | |
|
Resistance Level | $722.38 | 5 Day Moving Average | $709.7(0.14%) | 10 Day Moving Average | $714.67(-0.55%) | 20 Day Moving Average | $722.38(-1.61%) | To recent high | -7.3% | To recent low | 4.4% | Market Cap | $75.357b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |